4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta

Recommendations

Info

4. Hrvatski kongres kliniËke citologije / 1. Hrvatski simpozij analitiËke citologije / 2. Hrvatski simpozij citotehnologije 98 Klinička citologija - Usmena predavanja CYTOLOGY OF CERVICAL INTRAEPITHELIAL GLANDULAR LESIONS Ovanin-Rakić A1 , Mahovlić V1 Audy-Jurković S1 , Barišić A1 , Škopljanac-Mačina L1 Jurič D1 , Rajhvajn S1 , Ilić-Forko J2 , Babić D2 , Folnović D3 , Kani D4 1 Department of Gynecologic Cytology, University Department of Obstetrics and Gynecology, Zagreb University Hospital Center, Zagreb, Croatia 2University Department of Clinical Pathology, Zagreb University Hospital Center, Zagreb, Croatia 3 University Department of Gynecologic Oncology, Department of Obstetrics and Gynecology, Zagreb University Hospital Center, Zagreb, Croatia 4 Children’s Hospital Zagreb, Zagreb, Croatia Introduction. Cytological criteria for the identification of glandular intraepithelial lesions (GIL) have not yet been fully described, especially for the precursors of adenocarcinoma in situ (AIS), thus these lesions may frequently remain unrecognized. As most patients diagnosed with AIS or mild to moderate GIL (grades I, II) are free from clinical symptoms, cytology has a very responsible role in the detection of these lesions. Aim. The aim of the study was to achieve the most appropriate cytologic diagnosis of intraepithelial lesions of endocervical columnar epithelium, analyzing the cytology findings in patients with histologically verified AIS and GIL (I, II). Patients and Methods. The value of cytology in the detection and differential diagnosis was assessed in 123 patients with definitive histologic diagnosis of glandular lesions (AIS, n=13; GIL I, n=11; and GIL II, n=7), and glandular lesions associated with squamous component (AIS associated with cervical intraepithelial neoplasia (CIN) or invasive squamous cell carcinoma (SCC), n=58; GIL I or GIL II associated with CIN, n=28; and GIL associated with microinvasive squamous carcinoma (MIC), n=6). Results. In 95.1% of patients, lesions were detected by cytologic analysis that indicated additional diagnostic procedure. In terms of differential diagnosis, cytology showed higher accuracy in predicting lesion severity vs. type of epithelial alteration (75.6% vs. 55.3%) and abnormalities of columnar epithelium (95.7%; vs. 74.2%). The accuracy of cytology was higher in pure (AIS, 61.5% and GIL I, II, 22.2%) than in mixed lesions (25.9% and 20.6%). Conclusion. Continuous improvement in cervical specimens and cytodiagnostic skills, better understanding of intraepithelial adenocarcinoma and precursors, and their inclusion in the classification of cytologic and histologic findings are expected to upgrade the detection of these lesions, and to reduce the invasive cervical adenocarcinoma morbidity and mortality. ana.ovanin@gmail.com
Clinical Cytology - Oral Presentations THE VALUE OF CYTOLOGICAL SMEAR IN EVALUATION OF HEAD AND NECK NON- MELANOMA SKIN CANCER Pastorčić Grgić M1 , Ramljak V2 , Šarčević B3 , Gršić K1 , Pegan A4 1Department of Head and Neck Surgery, University Hospital for Tumours, Zagreb, Croatia 2Department of Clinical Cytology, University Hospital for Tumours, Zagreb, Croatia 3Department of Clinical Pathology, University Hospital for Tumours, Zagreb, Croatia 4Department of Otorhinolaryngology and Cervicofacial Surgery, University Hospital “Sisters of Mercy”, Zagreb, Croatia Non-melanoma skin cancer is the most common malignancy in humans. Although clinical recognition of typical tumours is usually sufficient, it is sometimes difficult to correctly diagnose atypical or recurrent tumours. Cytological sampling is painless, noninvasive and accurate method, useful in skin cancer evaluation. In our study, which included 91 patients, overall accuracy of cytological diagnosis in non-melanoma skin cancer was 91.2%. We find this method especially useful in differentiating small benign looking lesions, in multiple skin changes and in suspected recurrent skin cancer. marija_pastgrgic@yahoo.com 99 4 th Croatian Congress of Clinical Cytology / 1 st Croatian Symposium of Analytical Cytology / 2 nd Croatian Symposium of Cytotechnology
Page 1:
4. Hrvatski kongres kliniËke citol
Page 4 and 5:
Page 6 and 7:
Page 8 and 9:
Page 10 and 11:
Page 13 and 14:
Final programme and abstract book
Page 15:
UTORAK, 13.10.2009. SRIJEDA, 14.10.
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51: 4. Hrvatski kongres kliniËke citol
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194:
show all

4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta

Create successful ePaper yourself

Delete template?

Save as template?